Report
MarketLine Department
EUR 311.72 For Business Accounts Only

BioCryst Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary
Pharmaceuticals and Healthcare

Key Findings
Pharmaceuticals and Healthcare


Pharmaceuticals and Healthcare

Reasons To Buys
MarketLine

Key Highlights
United States
Underlying
BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is a biotechnology company that discovers oral, small-molecule medicines. The company focuses on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the main role in the biological pathway of the disease. The company's drug/drug candidates include: Berotralstat (BCX7353), an oral serine protease inhibitor targeting kallikrein that is being developed as a once-daily oral therapy for the prevention of Hereditary Angioedema; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; and BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive.

Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports on these Companies
Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch